On June 16, 2025, Aptevo Therapeutics Inc. entered into a Standby Equity Purchase Agreement with YA II PN, LTD. (Yorkville), allowing them the right to issue and sell up to $25 million of common stock over 36 months. The shares can be purchased by Yorkville at a price equal to 96% of the lowest daily VWAP during a three-day period, subject to certain conditions. The maximum number of shares that can be sold is capped at 151,755 unless certain conditions are met. No specific transaction details or number of shares sold are provided in the document.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.